The high frequency of molecular mutations (p53, RB, unmethylated MGMT) makes GBM less sensitive to conventional cytotoxic therapies and highly resistant to standard chemotherapy and radiotherapy [6]. The gene discussed is TP53; the disease is glioblastoma.